383 related articles for article (PubMed ID: 30931705)
1. Prescription Drug Monitoring Program Use: National Dental PBRN Results.
McCauley JL; Gilbert GH; Cochran DL; Gordan VV; Leite RS; Fillingim RB; Brady KT;
JDR Clin Trans Res; 2019 Apr; 4(2):178-186. PubMed ID: 30931705
[TBL] [Abstract][Full Text] [Related]
2. Opioid prescribing and risk mitigation implementation in the management of acute pain: Results from The National Dental Practice-Based Research Network.
McCauley JL; Leite RS; Gordan VV; Fillingim RB; Gilbert GH; Meyerowitz C; Cochran D; Rindal DB; Brady KT;
J Am Dent Assoc; 2018 May; 149(5):353-362. PubMed ID: 29550022
[TBL] [Abstract][Full Text] [Related]
3. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
[TBL] [Abstract][Full Text] [Related]
4. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.
McCauley JL; Leite RS; Melvin CL; Fillingim RB; Brady KT
Subst Abus; 2016; 37(1):9-14. PubMed ID: 26675303
[TBL] [Abstract][Full Text] [Related]
5. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
6. Training experiences regarding pain management, addiction, and drug diversion of dentists enrolled in the National Dental Practice-Based Research Network.
McCauley JL; Reyes S; Meyerowitz C; Gordan VV; Rindal DB; Gilbert GH; Leite RS; Fillingim RB; Brady KT;
Subst Abus; 2019; 40(3):344-349. PubMed ID: 30829128
[No Abstract] [Full Text] [Related]
7. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
Martello J; Cassidy B; Mitchell A
J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
[TBL] [Abstract][Full Text] [Related]
8. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
11. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
[TBL] [Abstract][Full Text] [Related]
12. Prescription Drug Abuse Among Patients in Rural Dental Practices Reported by Members of the National Dental PBRN.
McCauley JL; Nelson JD; Gilbert GH; Gordan V; Durand SH; Mungia R; Meyerowitz C; Leite RS; Fillingim RB; Brady KT;
J Rural Health; 2020 Mar; 36(2):145-151. PubMed ID: 31385367
[TBL] [Abstract][Full Text] [Related]
13. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
[TBL] [Abstract][Full Text] [Related]
14. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
[TBL] [Abstract][Full Text] [Related]
15. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
[TBL] [Abstract][Full Text] [Related]
16. National Estimates and Physician-Reported Impacts of Prescription Drug Monitoring Program Use.
Richwine C; Everson J
J Gen Intern Med; 2023 Mar; 38(4):881-888. PubMed ID: 36229762
[TBL] [Abstract][Full Text] [Related]
17. Opioid prescribing practices from 2010 through 2015 among dentists in the United States: What do claims data tell us?
Gupta N; Vujicic M; Blatz A
J Am Dent Assoc; 2018 Apr; 149(4):237-245.e6. PubMed ID: 29599017
[TBL] [Abstract][Full Text] [Related]
18. Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City.
Chernick R; Allen B; Harocopos A
J Behav Health Serv Res; 2022 Apr; 49(2):122-133. PubMed ID: 34426933
[TBL] [Abstract][Full Text] [Related]
19. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
20. How Are Real-time Opioid Prescribing Cognitions by Emergency Providers Influenced by Reviewing the State Prescription Drug Monitoring Program?
Landau A; Lynch M; Callaway C; Suffoletto B
Pain Med; 2019 May; 20(5):955-960. PubMed ID: 29762757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
